Gitelman syndrome: a review of clinical features, genetic diagnosis and therapeutic management

References

• Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:221–235.
   PubMedGoogle Scholar
• Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24–30.
   PubMed Web of Science ®Google Scholar
• Coto E, Rodriguez J, Jeck N, et al. A new mutation (intron 9 +1 G>T) in the SLC12A3 gene is linked to Gitelman syndrome in Gypsies. Kidney Int. 2004;65:25–29.
   PubMed Web of Science ®Google Scholar
• Lin SH, Shiang JC, Huang CC, et al. Phenotype and genotype analysis in Chinese patients with Gitelman’s syndrome. J Clin Endocrinol Metab. 2005;90:2500–2507.
   PubMed Web of Science ®Google Scholar
• Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18:1271–1283.
   PubMed Web of Science ®Google Scholar
• Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol. 2011;22:693–703.
   PubMed Web of Science ®Google Scholar
• Mejía N, Santos F, Claverie-Martín F, et al. RenalTube: a network tool for clinical and genetic diagnosis of primary tubulopathies. Eur J Pediatr. 2013;172:775–780.
   PubMed Web of Science ®Google Scholar
• Tavira B, Gómez J, Santos F, et al. A labor- and cost-effective non-optical semiconductor (Ion Torrent) next-generation sequencing of the SLC12A3 and CLCNKA/B genes in Gitelman’s syndrome patients. J Hum Genet. 2014;59:376–380.
   PubMed Web of Science ®Google Scholar
• Verhave JC, Bech AP, Wetzels JFM, et al. Hepatocyte nuclear factor 1β–associated kidney disease: more than renal cysts and diabetes. J Am Soc Nephrol. 2016;27:345–353.
   PubMed Web of Science ®Google Scholar
• Gamba G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol Rev. 2005;85:423–493.
   PubMed Web of Science ®Google Scholar
• Riancho JA, Saro G, Sañudo C, et al. Gitelman syndrome: genetic and expression analysis of the thiazide-sensitive sodium-chloride transporter in blood cells. Nephrol Dial Transplant. 2006;21:217–220.
   PubMed Web of Science ®Google Scholar
• Yang SS, Fang YW, Tseng MH, et al. Phosphorylation regulates NCC stability and transporter activity in vivo. J Am Soc Nephrol. 2013;24:1587–1597.
   PubMed Web of Science ®Google Scholar
• Zhang J, Siew K, Macartney T, et al. Critical role of the SPAK protein kinase CCT domain in controlling blood pressure. Hum Mol Genet. 2015;24:4545–4558.
   PubMed Web of Science ®Google Scholar
• Wilson FH, Disse-Nicodème S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107–1112.
   PubMed Web of Science ®Google Scholar
• Subramanya AR, Ellison DH. Distal convoluted tubule. Clin J Am Soc Nephrol. 2014;9:2147–2163.
   PubMed Web of Science ®Google Scholar
• Joo KW, Lee JW, Jang HR, et al. Reduced urinary excretion of thiazide-sensitive Na-Cl cotransporter in Gitelman syndrome: preliminary data. Am J Kidney Dis. 2007;50:765–773.
   PubMed Web of Science ®Google Scholar
• Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008;3:22.
   PubMed Web of Science ®Google Scholar
• Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59:710–717.
   PubMed Web of Science ®Google Scholar
• Herrero-Morín JD, Rodríguez J, Coto E, et al. Gitelman syndrome in Gypsy paediatric patients carrying the same intron 9 + 1 G>T mutation. Clinical features and impact on quality of life. Nephrol Dial Transplant. 2011;26:151–155.
   PubMed Web of Science ®Google Scholar
• Nijenhuis T, Vallon V, Van Der Kemp AW, et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115:1651–1658.
   PubMed Web of Science ®Google Scholar
• Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120:38–43.
   PubMed Web of Science ®Google Scholar
• Nozu K, Iijima K, Kanda K, et al. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. J Clin Endocrinol Metab. 2010;95:E511–8.
   Google Scholar
• Matsunoshita N, Nozu K, Shono A, et al. Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics. Genet Med. 2016;18:180–188.
   PubMed Web of Science ®Google Scholar
• Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007;2:454–460.
   PubMed Web of Science ®Google Scholar
• Hsu YJ, Yang SS, Cheng CJ, et al. Thiazide-sensitive Na+ -Cl- cotransporter (NCC) gene inactivation results in increased duodenal Ca2+ absorption, enhanced osteoblast differentiation and elevated bone mineral density. J Bone Miner Res. 2015;30:116–127.
   PubMed Web of Science ®Google Scholar
• Nicolet-Barousse L, Blanchard A, Roux C, et al. Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null mice. J Bone Miner Res. 2005;20:799–808.
   PubMed Web of Science ®Google Scholar
• Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension. 2001;37:1458–1464.
   PubMed Web of Science ®Google Scholar
• Ji W, Foo JN, O’Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592–599.
   PubMed Web of Science ®Google Scholar
• Fava C, Montagnana M, Rosberg L, et al. Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure. Hum Mol Genet. 2008;17:413–418.
   PubMed Web of Science ®Google Scholar
• Berry MR, Robinson C, Karet Frankl FE. Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements. Nephrol Dial Transplant. 2013;28:1533–1542.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Rodríguez-Morán M, Hernández-Ronquillo G, et al. Low serum magnesium levels and its association with high blood pressure in children. J Pediatr. 2016;168:93–98.
   PubMed Web of Science ®Google Scholar
• Fremont OT, Chan JC. Understanding Bartter syndrome and Gitelman syndrome. World J Pediatr. 2012;8:25–30.
   PubMed Web of Science ®Google Scholar
• Blanchard A, Vargas-Poussou R, Vallet M, et al. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. J Am Soc Nephrol. 2015;26:468–475.
   PubMed Web of Science ®Google Scholar
• Bettinelli A, Tosetto C, Colussi G, et al. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int. 2002;62:580–584.
   PubMed Web of Science ®Google Scholar